Source: FinanzNachrichten

Resalis received undisclosed amount in Equity Funding

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

CEO

Alessandro Toniolo

CEO Approval Rating

90/100

Resalis is an Italy-based biotechnology company that develops non-coding RNA therapies for the treatment of metabolic disorders.